Insights On Trial Design

  1. Proposals From The DIA/Harvard-MIT CRS CGT Executive Roundtable 5/15/2024

    Gain insight into the critical importance of proactive engagement, collaborative partnerships, and continuous education to navigate these challenges effectively.

  2. Everything You Need To Know About Mobile Visits And Community Sites 10/11/2024

    Discover how decentralized clinical trials (DCTs) and mobile visits contribute to more diverse, efficient, and patient-centric research, ultimately enhancing trial outcomes and data quality.

  3. Mental Health: 5 Facts About Psychedelics 10/16/2024

    As mental health issues surge globally, especially following the COVID-19 pandemic, renewed interest in psychedelic drugs is driving research into their potential therapeutic uses.

  4. Providing Access To Patients 9/9/2025

    We believe that delivering meaningful results begins with meeting patients where they are — whether in their homes, within their communities, or in familiar gathering places.

  5. Cell And Gene Therapy Field Quiet In Q2 8/15/2024

    While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.

  6. Meeting Eye Exam Needs At The Point Of Need 3/11/2025

    Learn more about how mobile vision clinics supported the staff at trial sites as well as the patients through the COVID-19 pandemic and beyond.

  7. Data Key In Addressing Patient Recruitment Challenges 6/19/2025

    Explore how a Phase II trial for extensive-stage and previously treated small cell lung cancer overcame recruitment challenges with a data-driven solution designed to surface protocol-matched patients.

  8. Quality By Design: Better Data Using Participant Insights 3/12/2024

    While clinical trials will always encounter challenges in driving quality experiences and data, there is one approach that’s backed by regulatory agencies and proven to lead to better outcomes.

  9. Gene Therapy In Neurology: The Case For Optimism 1/14/2025

    Advancements in genetic therapy are revolutionizing the treatment of neurological diseases, with promising results from preclinical studies leading to clinical trials focused on safety and efficacy.

  10. What Is The Role Of Large Language Models In RWE Generation? 4/28/2025

    Large language models (LLMs) are generative AI models that can analyze and curate large amounts of RWD - at an unprecedented scale and speed - to generate real-world evidence (RWE).